GLP-1 medications can trigger this disruption through at least five distinct mechanisms, sometimes acting alone, sometimes in combination
Some patients may experience improvements in sexual function, while others may notice no change or even temporary decreases due to factors such as caloric restriction, fatigue during the adjustment period, or gastrointestinal side effects that affect overall well-being
We believe in a transparent, science-backed approach that looks at the whole person, not just the number on the scale
Tirzepatide, which combines a long-acting glucose-dependent insulinotropic polypeptide (GIP) analog and a GLP-1 receptor agonist, selectively binds to and activates the GIP and GLP-1 receptors
Fuentes primarias verificadas que respaldan las afirmaciones cientficas de este artculo: 1
Cell (2016) 167:84357.e14